Wenxi Tan

Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer

Xiaolin Yu, Sharad Ghamande, Haitao Liu et al. · Molecular Therapy — Nucleic Acids · 2017 · 92 citations · Full text

Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling

Wenxi Tan, Ge Sun, Mengyuan Shangguan et al. · Scientific Reports · 2020 · 49 citations · Full text

FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer

Jing Zhao, Wenxi Tan, Lingyi Zhang et al. · Biochemical Pharmacology · 2021 · 37 citations

Medicine, Cancer Biology, Cell Biology +3

TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer

Wenxi Tan, Tianmin Xu, Zilong Zhou et al. · Oncology Reports · 2019 · 28 citations · Full text

Trp14 Induces, Cancer Biology, Tumor Biology +18

Combination of AZD2281 (Olaparib) and GX15-070 (Obatoclax) results in synergistic antitumor activities in preclinical models of pancreatic cancer

Shaohua Chen, Guan Wang, Xiaojia Niu et al. · Cancer Letters · 2014 · 27 citations

Oncology, Pancreatic Cancer, Preclinical Models +7